BRICS and the Iran war

Iran war tests BRICS — and reveals its limits

Despite calls for mediation, BRICS has remained fragmented, highlighting its role as a ‘club’ like the G7 rather than a forum for collective action. Read more »
electricity tariffs

India’s electricity tariffs hide the true cost of power

India’s power subsidies extend far beyond budgets, distorting electricity tariffs, hurting industry and weakening DISCOM finances. #DISCOM Read more »
Small savings rates

Small savings rates put government in a policy bind

India’s small savings rates expose a hard trade-off between fiscal discipline and the trust of risk-averse savers. #savings Read more »
india sports infrastructure

Missing sports infrastructure is a public health risk

India’s growth has outpaced its sports infrastructure, hurting public health and grassroots talent. Read more »
The global corporate tax system

Why the global corporate tax system needs a redesign

The global corporate tax system cannot keep up with digital business, mobile capital, and market-driven profits. #tax Read more »
West Asia

West Asia crisis exposes India’s export fragility

The West Asia conflict has exposed India’s export vulnerabilities in shipping, insurance and logistics. #WestAsia Read more »
AI-driven consumer manipulation in digital marketplace

India’s digital marketplace needs its own AI consumer safeguards

India’s data law is in place, but AI-driven consumer manipulation in digital marketplace still lacks a clear regulatory framework. Read more »
Amul success story

Amul’s success shows why cooperatives need to scale

Amul’s Rs 1 trillion milestone revives a hard question: can India build more farmer-owned institutions at scale? #Amul Read more »
state governments

Why state governments need more foreign policy capacity

As foreign capital deepens its reach, state governments need strategic capacity, not just investment offices. #policy Read more »
US drug tariffs put India’s CDMOs at risk

US drug tariffs put India’s CDMOs at risk

Proposed US drug tariffs may spare generics but will hit India’s higher-value pharma manufacturing ambitions. #drug #pharma #UStariffs Read more »